58P Intrahepatic cholangiocarcinoma (iCCA) hidden amongst the unknown: A retrospective analysis of cancer of unknown primary (CUP) cases from a tertiary cancer centre

Authors:

Abstract
No abstract available
Funding Information
  • Roche
  • GlaxoSmithKline
  • Novartis